Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maxing Zhixiao Granules for Bronchial Asthma (hot wheeze pattern) Phase III Trial
CTR20250204Phase 3Active
- Sponsor
- Jiangsu Kanion Pharmaceutical Co., Ltd.
- Start
- Mar 2025
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Maxing Zhixiao Granule in asthma, sponsored by Jiangsu Kanion Pharmaceutical Co., Ltd.. Started Mar 2025; status: active.
02
Drugs
Maxing Zhixiao Granule
03
Conditions
asthma
Beyond the preview
Go deeper on CTR20250204.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20250204.